Other news
News
Partner news
BaseLaunch announces that Johnson & Johnson Innovation has renewed its commitment becoming latest strategic partner in the second phase
Read full storyOther news
Dr. Sadasivan Vidyasagar, Associate Professor at University of Florida, and entrinsic bioscience CEO Stephen Gatto, Receive University of Florida's 'Invention of the Year 2020' Award
Read full storyOther news
XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer
Read full storyPartner news
ESCAPE Bio Closes $73 Million in Crossover Financing to Advance Clinical Development of Precision Neurology Medicines for Genetic Neurodegeneration
Read full storyPartner news
Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease
Read full storyPress release
Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration
Read full storyPress release
Johnson & Johnson Innovation and Janssen Announce the Awardees of the World Without Disease Call-for-Proposal
Read full storyPartner news
GI Windows Raises $16.4M in Series A-1 Financing
Read full storyPartner news
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases
Read full storyPartner news
ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing
Read full storyPartner news
Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors
Read full storyPartner news
ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate
Read full storyIn the media
Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine
Read full storyIn the media